Identification of RNA Modification-Associated Alternative Splicing Signature as an Independent Factor in Head and Neck Squamous Cell Carcinoma

Figure 5

Correlation between RMA-AS_Score prognostic signature and clinical features and construction of the clinicopathological map. (a–c) Correlation of risk score with gender, stage, and tumor grade. (d) The AUC of RMA-AS_Score prognostic signature and clinical parameters. (e) The AUC of 1-, 2-, and 3-year survival. (f) Nomogram was constructed by using RMA-AS_Score signature and clinical parameters. (g) The nomogram calibration plot in HNSCC.

(a)

(b)

(c)

(d)

(e)

(f)

(g)